Breaking News: Theracann and TruTrace Technologies Enter Collaboration Agreement to Validate Supply Chain for the Cannabis and Hemp Industry

Theracann International Benchmark Corporation, a leading full service international cannabis consultancy and technology firm in conjunction with TruTrace Technologies, (CSE: TTT) (OTC: BKKSF)  creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, announced today that they have signed a letter of intent dated June 19th, 2019 (the “LOI”) to explore opportunities to combine TruTrace’s StrainSecure™ technology with Theracann’s ETCH biotrace™ genetic tracking system for cannabis and hemp. 

The agreement will create the opportunity to integrate TheraCann’s ETCH biotrace platform uses both a physical molecular taggent and non-appendable Electronic Product Code Information Services (EPCIS) blockchain to provide forensic levels of traceability of cannabis and cannabis derivatives at any point in the supply chain with StrainSecure, TruTrace’s blockchain-based software designed to guarantee product quality and genetics from genome-to-patient. 

“Electronic Traceability for Cannabis and Hemp or ETCH uses a unique, safe and persistent molecular tag for the identification of any biomass, extraction, isolate, derivative or cannabis packaging. The molecular tag does not genetically modify the organism (non-GMO) and can be added or identified at any point within the supply chain,” said Jason Warnock, Chief Executive Officer of Theracann. “Collaborating with TruTrace connects the dots between the provenance of material, genetics, testing information and patient data that is so vital to the safety and efficacy of the global market.”

TruTrace Technologies has established working relationships with a number of complementary technology providers, and recently announced a pilot program for Canada’s largest pharmacy chain, Shoppers Drug Mart, to create a central hub for identity management, asset tracking, validation, and product authentication. 

“Creating an eco-system of technologies with the intent to provide patients, government, and the industry with supply chain integrity, true IP protection and analytical testing and validation is an important next step for the cannabis and hemp industry evolution,” says Robert Galarza, CEO of TruTrace Technologies. “We are excited to connect Theracann’s ETCH molecular track and trace system with StrainSecure and to explore additional opportunities for collaboration between our organizations.” 

Terms of the LOI:

Under the terms of the LOI, the parties have agreed that: (a) TruTrace will include Theracann as a preferred partner; and (b) the parties will explore development and integration opportunities to utilize their mutual technologies to bring greater transparency and visibility to the legal cannabis industry. The parties have agreed to negotiate, settle and execute a definitive agreement formalizing their relationship (the “Formal Agreement”) on or before July 31st, 2019. Entry into the Formal Agreement, and the closing of the transactions contemplated in it, are subject to certain conditions, including completion of each party’s satisfactory due diligence review of the other.

About Theracann International Benchmark Corporation

Founded in 2016, Theracann offers a full turn-key solution for the international cannabis marketplace. Theracann provides business, technology and industry experts who apply advanced methodologies that help clients plan, design, implement and manage their canna-businesses. Integrating indoor cannabis operations along with the successful groundbreaking Enterprise Resource Planning and Compliance (ERP+C) software OS2, their vertical computer automated cannabis aeroponic cultivation system (Sprout AI), and patented genetic molecular tracking (ETCH BioTrace). Theracann International provides canna-businesses with solutions to fit global banking and license regulatory requirements.

More information about theracann INTERNATIONAL is available at www.theracann.solutionswww.sproutai.solutionswww.etchbio.solutions, and www.OS2.solutions.

About TruTrace Technologies:

TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. Their technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of mandatory genetic quality control testing for legal cannabis. The technology is proprietary, immutable, and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.

Sponsored Content Release. Click for Full Disclosure

1 Comment
  1. Larry Dubois 3 weeks ago
    Reply

    good, when cannabis becomes mainstream enough, consumers will want to pay more for organic options. TruTrace’s technology can help track that.

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For trutrace technologies inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.